Pages that link to "Q73681270"
Jump to navigation
Jump to search
The following pages link to Effects of Marine Fish Oils on the Anticoagulation Status of Patients Receiving Chronic Warfarin Therapy (Q73681270):
Displaying 14 items.
- Concomitant use of prescription medications and dietary supplements in menopausal women: an approach to provider preparedness (Q30226808) (← links)
- N-3 fatty acids from fish and coronary artery disease: implications for public health. (Q33901597) (← links)
- Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review (Q34287966) (← links)
- Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters (Q34416861) (← links)
- Prevention of age-related macular degeneration (Q34491498) (← links)
- Fish oil for the treatment of cardiovascular disease. (Q35552231) (← links)
- Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia (Q36758082) (← links)
- The Use of Fish Oil with Warfarin Does Not Significantly Affect either the International Normalised Ratio or Incidence of Adverse Events in Patients with Atrial Fibrillation and Deep Vein Thrombosis: A Retrospective Study (Q37285924) (← links)
- Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment. (Q37586350) (← links)
- Essential fatty acids in the treatment of dry eye. (Q37682316) (← links)
- Important drug-nutrient interactions (Q43051294) (← links)
- Souvenaid®: a new approach to management of early Alzheimer's disease (Q43864462) (← links)
- Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: A randomized, controlled study (Q88593755) (← links)
- Fish oil supplementation and repeated macular hemorrhage without choroidal neovascularization: A case report (Q99711826) (← links)